These ideas for home based business can be started by people who wish to earn money while being in the convenience of their homes.
We're building the platform that solves shipping, at scale, globally! As a Medior Full-Stack Engineer, you won't be handed a slice of a feature and told to build your bit. You'll own features ...
Scientists statistically analyzed large amounts of data collected by Burmese python contractors, revealing critical insights about how to most efficiently remove the reptiles. In a groundbreaking ...
Modern fluorescence microscopy can generate images of living cells as stunning to look at as they are informative to study. For techniques like fluorescence lifetime imaging microscopy (FLIM), those ...
For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...
As tools like Claude Code get better, more and more developers are happy to hand off coding tasks to them. The way software gets built has changed for good. The vibes were strong at Code with Claude, ...
Thousands of Microsoft developers will use GitHub Copilot CLI instead Thousands of Microsoft developers will use GitHub Copilot CLI instead is a senior correspondent and author of Notepad, who has ...
Anthropic caused a stir among developers with what appeared to be a surprise change to its pricing plan: The company signaled that Claude Code, the popular agentic development tool, would no longer be ...
Anthropic inadvertently released internal source code behind its popular artificial-intelligence-powered Claude coding assistant, raising questions about the security of an AI model developer that has ...
What should have been a routine release has revealed some of the features Anthropic has been working on for Claude Code. As reported by Ars Technica, The Verge and others, after the company released ...
During a call with investors, many questions focused on MZE829’s competitiveness with Vertex’s APOL1 inhibitor inaxaplin. (Getty Images) Maze Therapeutics has revealed topline phase 2 data for its ...